SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-025123
Filing Date
2020-05-13
Accepted
2020-05-13 17:11:39
Documents
70
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alt-10q_20200331.htm 10-Q 1250131
2 EX-31.1 alt-ex311_10.htm EX-31.1 18167
3 EX-31.2 alt-ex312_6.htm EX-31.2 17898
4 EX-32.1 alt-ex321_9.htm EX-32.1 6182
5 EX-32.2 alt-ex322_11.htm EX-32.2 6147
  Complete submission text file 0001564590-20-025123.txt   5159270

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT alt-20200331.xml EX-101.INS 1061325
7 XBRL TAXONOMY EXTENSION SCHEMA alt-20200331.xsd EX-101.SCH 44778
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alt-20200331_cal.xml EX-101.CAL 52673
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alt-20200331_def.xml EX-101.DEF 134393
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE alt-20200331_lab.xml EX-101.LAB 368700
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alt-20200331_pre.xml EX-101.PRE 281449
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32587 | Film No.: 20874141
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences